Matches in Wikidata for { <http://www.wikidata.org/entity/Q88789352> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q88789352 description "artículu científicu espublizáu en mayu de 2018" @default.
- Q88789352 description "im Mai 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88789352 description "scientific article published on 21 May 2018" @default.
- Q88789352 description "wetenschappelijk artikel" @default.
- Q88789352 description "наукова стаття, опублікована в травні 2018" @default.
- Q88789352 name "Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study" @default.
- Q88789352 name "Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study" @default.
- Q88789352 type Item @default.
- Q88789352 label "Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study" @default.
- Q88789352 label "Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study" @default.
- Q88789352 prefLabel "Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study" @default.
- Q88789352 prefLabel "Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study" @default.
- Q88789352 P1104 Q88789352-6D20AA20-F5A7-46D3-9B4B-10C69FF82149 @default.
- Q88789352 P1433 Q88789352-73518BC9-D0BC-4A2A-8CC7-37D194353B91 @default.
- Q88789352 P1476 Q88789352-CAA8062D-1D77-4CEA-94A9-238562D3CCFE @default.
- Q88789352 P2093 Q88789352-53D124AB-2627-4F9A-BF5D-05FBB13A27FC @default.
- Q88789352 P2093 Q88789352-C8A15146-44FF-49F5-BE30-07A0280CBD06 @default.
- Q88789352 P2093 Q88789352-E650DA9E-B881-4C40-BC96-683571CC0AE2 @default.
- Q88789352 P2093 Q88789352-F65416BD-C388-4F23-95FC-624C415B7FFF @default.
- Q88789352 P304 Q88789352-067132A9-B1FD-4CDF-A265-DAB26EE07FEB @default.
- Q88789352 P31 Q88789352-352F8D66-3845-4A05-820E-A0E569486CDC @default.
- Q88789352 P356 Q88789352-A832F2DD-EE64-445D-BDF4-1C0497705157 @default.
- Q88789352 P478 Q88789352-07D2417D-B1EF-4955-A0D2-936B8CA8D1AF @default.
- Q88789352 P50 Q88789352-339254A6-E1AC-4BD8-BF3D-392E4F024172 @default.
- Q88789352 P50 Q88789352-AE6BA1CE-8AD1-487F-A407-2E3B0149513F @default.
- Q88789352 P577 Q88789352-4C58F01F-C937-48B4-815C-C8A6EC0DAB59 @default.
- Q88789352 P698 Q88789352-ADAB118A-9802-412C-8E48-653496980841 @default.
- Q88789352 P921 Q88789352-436CC342-1A19-4561-ADC0-378C4F9C8663 @default.
- Q88789352 P921 Q88789352-7BA2FE9F-7B7F-4C44-939A-D4C56EEFCDB4 @default.
- Q88789352 P356 J.IJBIOMAC.2018.05.142 @default.
- Q88789352 P698 29792967 @default.
- Q88789352 P1104 "+11" @default.
- Q88789352 P1433 Q6051322 @default.
- Q88789352 P1476 "Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study" @default.
- Q88789352 P2093 "Antonio Martínez-Ortega" @default.
- Q88789352 P2093 "Antonio Salmerón-García" @default.
- Q88789352 P2093 "José Cabeza" @default.
- Q88789352 P2093 "Natalia Navas" @default.
- Q88789352 P304 "993-1003" @default.
- Q88789352 P31 Q13442814 @default.
- Q88789352 P356 "10.1016/J.IJBIOMAC.2018.05.142" @default.
- Q88789352 P478 "116" @default.
- Q88789352 P50 Q63351216 @default.
- Q88789352 P50 Q73008813 @default.
- Q88789352 P577 "2018-05-21T00:00:00Z" @default.
- Q88789352 P698 "29792967" @default.
- Q88789352 P921 Q412616 @default.
- Q88789352 P921 Q413299 @default.